This inventor holds 2 USPTO granted patents. Top assignees: Cubist Pharmaceuticals, Incorporated, Xenova Limited. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Sangeeta Bahl: Innovator in Cytokine Production Inhibitors
Introduction
Sangeeta Bahl is a prominent inventor based in Slough, GB. She has made significant contributions to the field of biotechnology, particularly in the development of cytokine production inhibitors. With a total of 2 patents to her name, her work has implications for treating immunoinflammatory and cancerous conditions.
Latest Patents
Her latest patents include innovative compounds that act as cytokine production inhibitors and tyrosine kinase inhibitors. These compounds are characterized by complex chemical formulas, including variations where R can be hydrogen or C-C alkyl. The patents describe processes for producing these compounds from fungal strains and synthetic analogues, showcasing her expertise in both natural and synthetic chemistry.
Career Highlights
Throughout her career, Sangeeta has worked with notable companies such as Xenova Limited and Cubist Pharmaceuticals, Incorporated. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects.
Collaborations
Sangeeta has worked alongside esteemed colleagues, including Michael Moore and Steven Michael Martin. Their combined expertise has contributed to the advancement of her research and the successful development of her patented technologies.
Conclusion
Sangeeta Bahl's innovative work in cytokine production inhibitors highlights her significant role in biotechnology. Her contributions continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile